Global Pet Noise Anxiety Market Size study, by Product Type (Calming Aids, Behavioral Therapies, Medication), Animal Type (Dogs, Cats, Other Pets), Distribution Channel (Pet Stores, Online Retailers, Veterinary Clinics), Noise Type (Thunderstorms, Firewor

The Global Pet Noise Anxiety Market is valued approximately at USD 1.96 billion in 2023 and is anticipated to grow with a steady compound annual growth rate of more than 6.02% over the forecast period 2024-2032. With the rise in pet adoption across the globe, especially among urban households, concerns related to companion animal mental health have gained traction—pet noise anxiety being a pressing concern. This behavioral condition, often triggered by common loud noises such as thunderstorms or fireworks, can lead to severe distress and physical symptoms in pets. Responding to this growing issue, the market has evolved with a diverse array of products and services—from pheromone diffusers and CBD-based calming aids to professional behavioral therapies—designed to cater to pet owners’ increasing demand for effective and holistic anxiety management solutions.

This expanding market is being propelled by increased awareness about animal well-being and a marked shift in consumer behavior, wherein pets are increasingly considered part of the family. As veterinary professionals continue to advocate for early diagnosis and proactive treatment of behavioral issues, demand for both over-the-counter calming products and clinical therapies has surged. The availability of innovative medications and non-invasive treatments has further enriched the market landscape. Additionally, the growing influence of pet influencers and social media advocacy has significantly accelerated consumer education, bolstering market growth and acceptance of noise anxiety treatment as a necessary component of pet healthcare.

Concurrently, technological advancements in product formulation and the surge in online distribution channels have played a pivotal role in market expansion. Brands are increasingly investing in R&D to develop pet-safe calming solutions and targeting specific anxiety triggers through multi-sensory products. Moreover, pet owners today seek convenience and accessibility, pushing manufacturers to expand their footprint across e-commerce platforms, where tailored marketing and targeted ads enhance product visibility. These trends collectively reflect the shift from reactive to preventative care models in pet wellness—paving the way for sustained market performance over the forecast period.

Furthermore, several companies have begun to incorporate telehealth and virtual behavioral consultations as part of bundled offerings, making therapy more accessible and personalized. This is particularly beneficial in suburban and rural areas where specialty veterinary services might be limited. On the regulatory front, increasing scrutiny around animal product safety has prompted industry players to adopt transparent labeling practices and clinical validations—raising consumer confidence and reinforcing product credibility. Nonetheless, high product costs and the subjective nature of behavioral treatments present ongoing challenges, particularly in developing regions where pet healthcare expenditure remains comparatively lower.

The global market landscape demonstrates regional nuances, with North America leading the pack due to heightened pet ownership rates, advanced veterinary infrastructure, and favorable reimbursement policies for animal therapies. Europe follows closely, with countries like Germany and the UK demonstrating robust demand for both therapeutic and natural remedies. Meanwhile, Asia Pacific is anticipated to witness the fastest growth rate, spurred by urbanization, increasing disposable income, and evolving attitudes toward pet parenting. The region’s rising digital adoption also enables rapid e-commerce penetration, particularly in emerging markets such as India and China, thereby offering substantial growth potential for industry stakeholders.

Major market player included in this report are:
• Vetoquinol S.A.
• Ceva Santé Animale
• Zoetis Inc.
• Elanco Animal Health Incorporated
• Nutramax Laboratories, Inc.
• PetIQ, Inc.
• Boehringer Ingelheim International GmbH
• PetMed Express, Inc.
• Manna Pro Products, LLC
• Virbac S.A.
• Medterra CBD
• Comfort Zone
• ThunderWorks
• Zesty Paws
• Pet Naturals of Vermont

The detailed segments and sub-segment of the market are explained below:

By Product Type
• Calming Aids
• Behavioral Therapies
• Medication

By Animal Type
• Dogs
• Cats
• Other Pets

By Distribution Channel
• Pet Stores
• Online Retailers
• Veterinary Clinics

By Noise Type
• Thunderstorms
• Fireworks
• Loud Noises
• Separation Anxiety

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

Historical year – 2022

Base year – 2023

Forecast period – 2024 to 2032

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.